Frontiers
US$ 27.54
shortage of glp-1 receptor agonists The agonist shortage: What you need to know and do GLP-1 receptor agonist shortage expected
Description
With game-changing clinical outcomes and skyrocketing demand, Eli Lilly is challenging Novos dominance in the booming obesity drug market
We used R version 4.2.2 (R Foundation for Statistical Computing, Vienna, Austria) along with the packages metafor and meta to carry out the analyses
Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells
Shorakae S, Teede H, De Courten B, Lambert G, Boyle J, Moran LJ
Diabetes 16 , e70014 (2024)
GLP-1RAs showed significantly more reduction of cardiovascular endpoints than other second- or third-line glucose-lowering medications
